Latest News
For investors, analyzing hundreds of stocks simultaneously is a daily challenge. We often rely on stock heatmaps to quickly get an overview of the S&P 500, Nasdaq 100, or the Dow 30. But most tools we use have a fundamental design problem: they don't adapt to what you actually want to see. The problem with [...]
Via Visibility · January 16, 2026
Vistra is ready to capitalize as tech and AI giants search for more electricity.
Via The Motley Fool · January 17, 2026
This beaten-down tech stock could see a solid turnaround in its fortunes in the new year.
Via The Motley Fool · January 17, 2026
Cryptocurrencies are coming off a rough year in 2025, but there could be significant upside ahead over the long term.
Via The Motley Fool · January 17, 2026
Need a higher retirement paycheck? Here's how to get it.
Via The Motley Fool · January 17, 2026
Expense differences and fund scale may impact which gold ETF best fits your portfolio strategy.
Via The Motley Fool · January 17, 2026
The next quarterly earnings update could extend the positive trends taking shape.
Via The Motley Fool · January 17, 2026
FMC isn't the agriculture play right now; it's Deere & Co., the company bringing AI and automation to the farm of tomorrow.
Via The Motley Fool · January 17, 2026
Donald Trump started 2026 by announcing a plan to increase annual military spending by $600 billion for next year – meaning that the military budget would reach a total of $1.5 trillion.
Via Talk Markets · January 17, 2026
The primary factors that were boosting Alphabet's stock price last year are gone.
Via The Motley Fool · January 17, 2026
Via Benzinga · January 17, 2026
Explore how cost, yield, and diversification set these two consumer staples ETFs apart for investors seeking defensive exposure.
Via The Motley Fool · January 17, 2026
2026 is shaping up to be a pivotal year for the electric vehicle startup.
Via The Motley Fool · January 17, 2026
Markets entered the week at record levels and were challenged by a wave of political and geopolitical headlines that tested investor confidence. Policy rhetoric weighed on the financial sector, and geopolitics continued to influence energy stocks.
Via Talk Markets · January 17, 2026
Explore how portfolio breadth, yield, and sector focus set these two consumer staples ETFs apart for globally minded investors.
Via The Motley Fool · January 17, 2026
Microsoft's OpenAI investment could infuse cash into its business at the right time.
Via The Motley Fool · January 17, 2026
Explore how sector balance, income potential, and risk profiles set these two popular ETFs apart for different investor needs.
Via The Motley Fool · January 17, 2026
The S&P 500 seems to be stuck. Money is rotating inside equities but not flowing in. Bonds are selling off. This is just not the time to chase high-flyers. With all of this in mind, I'm looking at one number before I buy anything right now: beta.
Via Talk Markets · January 17, 2026
Archer Aviation holds an early leadership position in eVTOLs, but this stock may be a better long-term investment.
Via The Motley Fool · January 17, 2026
Trump unveiled a Gaza "Board of Peace" led by him and featuring Rubio, Blair, and Witkoff to oversee governance, reconstruction, and security plans.
Via Benzinga · January 17, 2026
This dog-themed meme coin has soared in the past five years, but the volatility has been difficult to stomach.
Via The Motley Fool · January 17, 2026
In a recent bankruptcy auction, a bulletproof Mercedes-Benz Maybach S650 once owned by ex-billionaire Miles Guo fetched a winning bid of $63,000.
Via Benzinga · January 17, 2026
With the fourth-quarter 2025 earnings season about to start, investors are zeroing in on three pure-play quantum computing stocks poised to deliver solid results: D-Wave Quantum, Rigetti, and IonQ. How should investors approach these stocks?
Via Talk Markets · January 17, 2026
Expense ratios, risk profiles, and portfolio makeup set these two metal funds apart—see how their differences could impact your strategy.
Via The Motley Fool · January 17, 2026
Biotech innovator Alumis, focused on autoimmune therapies, reported a significant insider buy amid a year of robust stock gains.
Via The Motley Fool · January 17, 2026